Medexus Pharmaceuticals Inc.
MEDXF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $2 | -$0 | $1 | -$3 |
| Dep. & Amort. | $7 | $6 | $6 | $6 |
| Deferred Tax | -$1 | $0 | -$6 | -$1 |
| Stock-Based Comp. | $0 | $0 | $1 | $2 |
| Change in WC | $6 | $2 | -$15 | $5 |
| Other Non-Cash | $9 | $10 | $12 | -$10 |
| Operating Cash Flow | $24 | $19 | -$1 | -$1 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$8 |
| Net Acquisitions | -$3 | -$3 | -$1 | -$0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$3 | -$0 | -$0 | -$10 |
| Investing Cash Flow | -$6 | -$3 | -$2 | -$8 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$14 | -$26 | $11 | $4 |
| Stock Issued | $19 | $8 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$4 | -$4 | -$4 | $1 |
| Financing Cash Flow | $1 | -$23 | $6 | $1 |
| Forex Effect | -$0 | -$0 | -$0 | $0 |
| Net Chg. in Cash | $19 | -$8 | $3 | -$9 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $5 | $13 | $10 | $19 |
| End Cash | $24 | $5 | $13 | $10 |
| Free Cash Flow | $21 | $18 | -$2 | -$9 |